Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Why Arrowhead Pharmaceuticals Shares Dropped 15% in February

TheMotleyFool

0 0

Why Arrowhead Pharmaceuticals Shares Dropped 15% in FebruaryPhoto, wide shot, wide-angle lens, Clinical research organization, Blue hour, twilight, cool, ISO1200, slow shutter speed, photo by Michael Light: https://img.theapi.app/temp/c28f6640-54ba-4d2b-afbe-b5fd3b0ee19e.png

Arrowhead Pharmaceuticals (NASDAQ: ARWR), a market darling in 2019, lost 15% of its valuation in February, according to data provided by S&P Global Market Intelligence. This is part of a larger free fall in the biotech's stock price in 2020. Arrowhead's valuation has dropped almost 50% since Jan. 2.

While some of this fall is due to fears from COVID-19, the stock started dropping way before that was an issue. So what's going on?

Image source: Getty Images.

Source Fool.com

Like: 0

ARWR

Teilen